- Home
- SVRE vs SHPH Comparison
SVRE vs SHPH Comparison
Compare SVRE & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- SHPH
- Stock Information
- Founded
- SVRE 2014
- SHPH 2012
- Country
- SVRE Israel
- SHPH United States
- Employees
- SVRE N/A
- SHPH N/A
- Industry
- SVRE
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- SVRE
- SHPH Health Care
- Exchange
- SVRE Nasdaq
- SHPH Nasdaq
- Market Cap
- SVRE 2.8M
- SHPH 3.2M
- IPO Year
- SVRE 2022
- SHPH 2022
- Fundamental
- Price
- SVRE $0.88
- SHPH $0.84
- Analyst Decision
- SVRE
- SHPH
- Analyst Count
- SVRE 0
- SHPH 0
- Target Price
- SVRE N/A
- SHPH N/A
- AVG Volume (30 Days)
- SVRE 644.4K
- SHPH 115.9K
- Earning Date
- SVRE 08-27-2024
- SHPH 11-13-2024
- Dividend Yield
- SVRE N/A
- SHPH N/A
- EPS Growth
- SVRE N/A
- SHPH N/A
- EPS
- SVRE N/A
- SHPH N/A
- Revenue
- SVRE $458,952.00
- SHPH N/A
- Revenue This Year
- SVRE N/A
- SHPH N/A
- Revenue Next Year
- SVRE $422.52
- SHPH N/A
- P/E Ratio
- SVRE N/A
- SHPH N/A
- Revenue Growth
- SVRE N/A
- SHPH N/A
- 52 Week Low
- SVRE $0.80
- SHPH $0.58
- 52 Week High
- SVRE $27.00
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- SVRE 42.74
- SHPH 49.54
- Support Level
- SVRE $0.80
- SHPH $0.83
- Resistance Level
- SVRE $0.94
- SHPH $0.92
- Average True Range (ATR)
- SVRE 0.10
- SHPH 0.08
- MACD
- SVRE 0.00
- SHPH 0.01
- Stochastic Oscillator
- SVRE 15.23
- SHPH 51.97
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.